BEACON CRC: Safety lead-in (SLI) for the combination of binimetinib (BINI), encorafenib (ENCO), and cetuximab (CTX) in patients (pts) with BRAF-V600E metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Huijberts, S.; Schellens, J. H. M.; Elez, E.; Cuyle, P. J.; Van Cutsem, E.; Yaeger, R.; Fakih, M.; Montagut, C.; Peeters, M.; Desai, J.; Yoshino, T.; Ciardiello, F.; Wasan, H.; Grothey, A.; Maharry, K.; Gollerkeri, A.; Kopetz, S. |
| Abstract Title: | BEACON CRC: Safety lead-in (SLI) for the combination of binimetinib (BINI), encorafenib (ENCO), and cetuximab (CTX) in patients (pts) with BRAF-V600E metastatic colorectal cancer (mCRC) |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx393.043 |
| Language: | English |
| ACCESSION: | WOS:000411324004288 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx393.043 |
| Notes: | Meeting Abstract: 517P -- Appears on page 175 of the abstract book -- Source: Wos |
